Mazzotta G, Bonow R O, Pace L, Brittain E, Epstein S E
Cardiology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.
J Am Coll Cardiol. 1989 Mar 1;13(3):567-73. doi: 10.1016/0735-1097(89)90594-9.
The randomized multicenter trials indicate that survival in patients with coronary artery disease and left ventricular dysfunction is enhanced by surgical therapy compared with medical therapy. This beneficial effect of coronary bypass surgery was demonstrated in patients with either three vessel or left main coronary artery disease, but not in those with one or two vessel disease. To determine whether subgroups of mildly symptomatic patients with one or two vessel coronary artery disease and left ventricular dysfunction have an increased risk of death or cardiac events during medical therapy, 53 consecutive patients with angiographically defined one or two vessel disease and impaired left ventricular function (ejection fraction 20% to 40%) were studied by exercise electrocardiography (ECG) and rest and exercise radionuclide angiography. All but two patients had previous myocardial infarction, and all were asymptomatic or only mildly symptomatic during medical therapy. By univariate life table analysis, mortality during medical therapy was associated significantly with the ST segment response to exercise (p less than 0.05) and with both the exercise ejection fraction (p less than 0.05) and the magnitude of change in ejection fraction with exercise (p less than 0.005). In patients with an exercise ejection fraction greater than 30%, the probability of survival at 6 years was 97 +/- 3% (+/- SE) compared with a survival rate of 62 +/- 14% in the remaining subjects (p less than 0.005). Similarly, 6 year survival was 100% in patients whose ejection fraction increased from the value at rest but was only 74 +/- 10% in the remaining patients (p less than 0.005). Exercise capacity was not associated with survival.(ABSTRACT TRUNCATED AT 250 WORDS)
随机多中心试验表明,与药物治疗相比,手术治疗可提高冠心病合并左心室功能不全患者的生存率。冠状动脉搭桥手术的这种有益效果在三支血管或左主干冠状动脉疾病患者中得到证实,但在单支或双支血管疾病患者中未得到证实。为了确定轻度症状的单支或双支血管冠状动脉疾病合并左心室功能不全患者亚组在药物治疗期间死亡或发生心脏事件的风险是否增加,我们通过运动心电图(ECG)以及静息和运动放射性核素血管造影对53例经血管造影确诊为单支或双支血管疾病且左心室功能受损(射血分数20%至40%)的连续患者进行了研究。除两名患者外,所有患者既往均有心肌梗死,且在药物治疗期间均无症状或仅有轻度症状。通过单变量寿命表分析,药物治疗期间的死亡率与运动时ST段反应显著相关(p<0.05),与运动射血分数(p<0.05)以及运动时射血分数的变化幅度(p<0.005)均显著相关。运动射血分数大于30%的患者,6年生存率为97±3%(±标准误),而其余患者的生存率为62±14%(p<0.005)。同样,静息射血分数增加的患者6年生存率为100%,而其余患者仅为74±10%(p<0.005)。运动能力与生存率无关。(摘要截断于250字)